Accustem Sciences (ACUT) Assets (2021 - 2026)
Accustem Sciences (ACUT) posted quarterly Assets of $1.5 million for Q1 2026, little changed year-over-year from $1.6 million in Q1 2025, and little changed quarter-over-quarter from $1.5 million in Q4 2025.
Accustem Sciences (ACUT) Assets (2021 - 2026) Analysis & Trends
Accustem Sciences (ACUT) has reported Assets for 6 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets changed 0.07% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (changed 0.07% YoY), while the FY2025 annual figure was $1.5 million, up 2947.03% from the prior year.
- Assets steadied at $1.5 million in Q1 2026 per ACUT's latest filing, from $1.5 million in the prior quarter.
- Across five years, Assets topped out at $3.3 million in Q1 2022 and bottomed at $50851.0 in Q4 2024.
- Historically, Assets has averaged $1.0 million across 5 years, with a median of $939689.0 in 2022.
- Annual changes were most pronounced in 2023 — Assets plunged 92.39% — and 2025, when it soared 2947.03%.
- Accustem Sciences' Assets stood at $939689.0 in 2022, then plunged by 85.75% to $133897.0 in 2023, then plunged by 62.02% to $50851.0 in 2024, then jumped by 2947.03% to $1.5 million in 2025, then climbed by 0.01% to $1.5 million in 2026.
- Business Quant data shows ACUT's Assets at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 19.82 Bn |
| 10 | Accustem Sciences | 2.57 Mn | 2.56 Mn | - | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 50,851.00 |
| Sep 30, 2024 | 103,819.00 |
| Jun 30, 2024 | 139,660.00 |
| Mar 31, 2024 | 50,941.00 |
| Dec 31, 2023 | 133,897.00 |
| Sep 30, 2023 | 257,575.00 |
| Jun 30, 2023 | 458,530.00 |
| Mar 31, 2023 | 247,559.00 |
| Dec 31, 2022 | 939,689.00 |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 2.38 Mn |
| Mar 31, 2022 | 3.25 Mn |
| Dec 31, 2021 | 1.35 Mn |